Research Frontiers (REFR) Q3 2026 Earnings Call Transcript

Research Frontiers (REFR) reported Q3 2026 earnings, highlighting supply chain disruptions due to Gauzy's financial issues, which impacted SPD material production and royalties. The company saw a net loss of $510,000, with fee income at $77,000. Gauzy's recent debt settlement and financing aim to restart production, crucial for REFR's royalty income. REFR has $645,000 in cash and is focused on restoring supply and evaluating long-term resilience.

Original reporting
Published Nov 6, 2026, 5:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 5:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Research Frontiers (REFR) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$REFRBearishLow
01

Why it matters

The Q3 2026 earnings reveal a steep revenue drop and widening loss, reflecting the ongoing supply chain constraints. No new financing or contract was announced to offset the weakness, suggesting near‑term headwinds.

02

Market read

The earnings release provides the first public view of REFR's Q3 2026 performance, indicating short‑term weakness but also outlining steps to restore supply. Traders should weigh the downside risk against potential upside from supply‑chain resolution.

03

What to watch

Potential upside from upcoming automotive glazing contracts and the $7 million financing to restart production, which could improve future royalties.

Relevance 6/10Novelty 6/10Timing: post‑earnings release today

Background

Research Frontiers (REFR) is a micro‑cap licensor of SPD light‑control technology. The company relies on partner manufacturers for production, and recent legal and financing troubles at its key partner Gauzy disrupted supply.

Company-level read

Ticker impact

$REFRBearishMedium confidence
Context

Research Frontiers disclosed Q3 2026 earnings, including fee income of $77k, net loss of $510k, and cash of $645k.

Expected impact

likely downward pressure as investors digest lower fee income and higher loss.

Evidence & confidence

Micro‑cap earnings with declining revenue typically trigger sell‑side activity; no new contract or financing offsetting the loss was announced.

Market effects

Highlights fragility of niche SPD technology licensing model; may caution investors in similar royalty‑based microcaps.

Limited to US micro‑cap segment; no broader regional effect.

Minimal global impact; only relevant to investors tracking niche optical‑film licensors.

Counterpoint

If the supply chain issues resolve quickly, the royalty model could generate high operating leverage, making the current dip a buying opportunity.

Key entities

  • Research Frontiers

    Publicly listed licensor of SPD technology (ticker REFR).

  • Gauzy

    Key manufacturing partner facing court‑supervised rehabilitation in France.

Related articles

$TNYZFMed

Tiny Ltd (TNYZF) (Q3 2026) Earnings Call Highlights: Record 25% EBITDA Margin, Leverage Cut

Tiny Ltd (TNYZF) reported Q3 2026 earnings with a record 25% adjusted EBITDA margin, reduced net leverage to 2.3x, and acquired Oso Cloud for $5.3M ARR. Metalab saw 25% sequential revenue growth, while organic revenue was flat. Free cash flow improved to $8.6M. Management cautioned about sustainability of Metalab's performance and noted cost-cutting benefits are largely realized.

$SAROMed

StandardAero (SARO) Q3 2026 Earnings Call Transcript

StandardAero reported Q3 2026 earnings with 30% year-over-year adjusted EPS growth, 15% adjusted EBITDA growth, and a 130 basis points adjusted EBITDA margin expansion to 14.4%. Revenue grew across commercial aerospace, business aviation, and military & helicopter sectors. The company highlighted strong demand visibility and strategic investments driving long-term growth.

$PCTYHighAI 8/10

Paylocity (PCTY) Q1 2027 Earnings Call Transcript

Paylocity (PCTY) reported Q1 2027 recurring revenue of $424.5M, up 12% YoY, and total revenue of $451.7M, up 11%. The company launched Recruiting Optimizer, an AI-driven tool that improved recruiting productivity by 35% and filled roles 25% faster. Paylocity raised fiscal 2027 guidance and repurchased 1.1M shares at $139 each. The company highlighted strong client adoption of its AI platform and received industry recognitions.

$AHRHighAI 8/10

Healthcare REIT (AHR) Q3 2026 Earnings Call Transcript

American Healthcare REIT (AHR) reported Q3 2026 earnings with same-store NOI growth of 13.8%, raising full-year NFFO per diluted share growth guidance to over 30%. The company completed $2.1B in investments and has a $1B pipeline, while maintaining a net debt to EBITDA ratio of 1.9x. AHR emphasized its strategy of organic growth, accretive investments, and balance sheet management.